Bulut, E. Et Al. 2024. CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway. CRISPRMED24 , (Kobenhavn, Denmark), 44.

Bulut, E., Çeçener, G., Huriyet, N., Balaban, R. F., Gökgöz, M. Ş., Öztürk Nazlıoğlu, H., ... Özkaya, G.(2024). CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway . CRISPRMED24 (pp.44). Kobenhavn, Denmark

Bulut, Ebrucan Et Al. "CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway," CRISPRMED24, Kobenhavn, Denmark, 2024

Bulut, Ebrucan Et Al. "CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway." CRISPRMED24 , Kobenhavn, Denmark, pp.44, 2024

Bulut, E. Et Al. (2024) . "CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway." CRISPRMED24 , Kobenhavn, Denmark, p.44.

@conferencepaper{conferencepaper, author={Ebrucan Bulut Et Al. }, title={CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway}, congress name={CRISPRMED24}, city={Kobenhavn}, country={Denmark}, year={2024}, pages={44} }